Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

Conditions:   Hepatocellular Carcinoma;   Chemotherapy Effect;   Chemotherapeutic Toxicity Interventions:   Drug: Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU;   Drug: Concurrent Lenvatinib;   Drug: Concurrent PD-1 antibody;   Drug: Sequential Lenvatinib;   Drug: Sequential PD-1 antibody Sponsors:   Sun Yat-sen University;   The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine;   Affiliated Hospital of Guangdong Medical University;   First People's Hospital of Foshan Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials